Researchers continue to excited about the medication , a novel dual agonist showing significant outcomes in clinical trials for weight loss . It works by targeting both systems: GLP-1 and GIP, which , https://ihannaqavp738400.full-design.com/the-new-prospect-for-weight-loss-83377661